Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals

Completed · Not applicable · Has a placebo group

Conditions studied: Age-associated Memory Impairment

In brief

The purpose of this study is to evaluate if BrainPhyt, a microalgae based ingredient may affect cognitive function parameters in older healthy individuals with evidence of age-related cognitive decline. In a double blind, randomized manner, 40 free living males and females between 55 to 75 years with age-associated memory decline will ingest Brainphyt supplement or Placebo for 12 weeks. Cognitive function battery will be realized after 4 and 12 weeks of supplementation.

Key facts

Study ID

NCT05759910

Run by

Microphyt

People needed

40

Starts

2022-05-01

Expected to finish

2023-11-01

Last updated by the study team

2023-11-08

Who can join

Age: 55 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Be able to give written informed consent and to consume the investigational product daily for the duration of the study.
• Healthy males and females aged ≥ 55 and ≤ 75 years old.
• Body-mass index between 18.5 and 35.0 kg/m2
• Is free-living (living in a private home, alone or with family, and able to maintain their health and hygiene without assistance).
• Have age-associated memory impairment (AAMI) based on the following National Institute of Mental Health criteria, specified as scoring:
• Absence of dementia as determined by a score of >24 on the Mini Mental State Examination (MMSE).
• ≤29 or ≤9 on the VPA I and II portions of the Wechsler Memory Scale IV, respectively
• A score on the MAC-Q of ≥25.
• Is in general good health, as determined by the investigator
• Ability to comply and understand the cognitive function practice tests
• Willing to maintain their habitual diet and exercise routines.
• Willing to maintain consistent sleep duration the evening before study visits.

You may not qualify if…

• Use of medications or supplements known to alter cognitive function within past 2 weeks
• Abnormal clinical laboratory test that may affect study outcome.
• History or presence of clinically important cardiac, renal, hepatic, endocrine, pulmonary, biliary, gastrointestinal, pancreatic, or neurological disorders (including sleep disorders, head injuries, Alzheimer's disease, Parkinson's disease, stroke, inflammatory brain disease
• History or presence of cancer, except nonmelanoma skin cancer
• Uncontrolled hypertension/diabetes
• History of depression within past 24 months or use of psychotropic medications within 1 month of screening
• Planned major changes in lifestyle (i.e. diet, dieting, exercise level, travelling) during the duration of the study.
• History within previous 12 months of alcohol or substance abuse.
• History of heavy smoking (>1 pack/day) within past 3 months

Where it is running

• Exercise & Sport Nutrition Lab — College Station, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.